Pesquisar
LakeShore Biopharma Co Ltd
LSBAdicionar à lista de desejos
0.627USD
0.0000.00%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
13.02MValor de mercado
--P/L TTM
Mais detalhes de LakeShore Biopharma Co Ltd Empresa
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Informações de LakeShore Biopharma Co Ltd
Código da empresaLSB
Nome da EmpresaLakeShore Biopharma Co Ltd
Data de listagemJul 30, 2021
CEOMr. Dave Chenn
Número de funcionários573
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 30
EndereçoBuilding No. 2, 38 Yongda Road
CidadeBEIJING
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísChina
Código postal102629
Telefone
Sitehttps://www.ysbiopharm.com/
Código da empresaLSB
Data de listagemJul 30, 2021
CEOMr. Dave Chenn
Executivos da empresa LakeShore Biopharma Co Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Ajit Shetty
Dr. Ajit Shetty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Thomas Xue
Mr. Thomas Xue
Director
Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de LakeShore Biopharma Co Ltd?
Os cinco principais acionistas de LakeShore Biopharma Co Ltd são: Mr. Yi Zhang
Quantas instituições possuem ações da LakeShore Biopharma Co Ltd (LSB)?
Em 2026Q1, 18 instituições possuíam ações da LakeShore Biopharma Co Ltd, com valor de mercado aproximado de 606.46K, representando 1.47% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1434782.00.